IN2014DN04596A - - Google Patents
Info
- Publication number
- IN2014DN04596A IN2014DN04596A IN4596DEN2014A IN2014DN04596A IN 2014DN04596 A IN2014DN04596 A IN 2014DN04596A IN 4596DEN2014 A IN4596DEN2014 A IN 4596DEN2014A IN 2014DN04596 A IN2014DN04596 A IN 2014DN04596A
- Authority
- IN
- India
- Prior art keywords
- cancer
- complexes
- relates
- present
- diagnosing
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical class P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 239000004332 silver Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to the use of silver(l) monophosphine complexes as Active Pharmaceutical Ingredients (API s) including anticancer agents for the treatment diagnosis and/or prevention of cancer. The present invention also relates to pharmaceutical compositions containing such complexes and further extends to a method of treating or diagnosing a subject/patient suffering from cancer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA201108944 | 2011-12-06 | ||
| PCT/IB2012/057029 WO2013084185A1 (en) | 2011-12-06 | 2012-12-06 | Use of silver (i) complexes as anticancer agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN04596A true IN2014DN04596A (en) | 2015-05-08 |
Family
ID=47557421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4596DEN2014 IN2014DN04596A (en) | 2011-12-06 | 2012-12-06 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9676801B2 (en) |
| EP (1) | EP2788007B1 (en) |
| AU (1) | AU2012348569B2 (en) |
| CA (1) | CA2858325C (en) |
| IN (1) | IN2014DN04596A (en) |
| WO (1) | WO2013084185A1 (en) |
| ZA (1) | ZA201404068B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109705158B (en) * | 2019-01-14 | 2021-01-05 | 温州大学新材料与产业技术研究院 | Independent double-center Ag complex and preparation method and anticancer activity evaluation thereof |
| CN110028526B (en) * | 2019-05-20 | 2021-07-13 | 福州大学 | Inorganic-organic hybrid materials with high water stability combined with blue-green emission and photoelectric response properties |
| CN110041364A (en) * | 2019-05-28 | 2019-07-23 | 福建医科大学附属协和医院 | It is a kind of have both blue green light shine, the inorganic organic multi-functional hybrid material of high water stability of antibacterial and photoelectric respone |
| BR102019022373A2 (en) * | 2019-10-24 | 2021-05-04 | Universidade Estadual De Campinas - Unicamp | process of obtaining cb-ag-nms and cb-ag-paba devices, cb-ag-nms and cb-ag-paba devices and use of cb-ag-nms and cb-ag-paba devices |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857549A (en) | 1984-02-01 | 1989-08-15 | Smithkline Beckman Corporation | Antitumor compounds |
| EP0668287B1 (en) * | 1988-12-02 | 2000-05-24 | Celanese Chemicals Europe GmbH | Sulfonated phenyl phosphine-containing complexes |
| KR100772790B1 (en) * | 2002-04-30 | 2007-11-01 | 삼성전자주식회사 | Organometallic precursor for metal pattern formation and metal pattern formation method using the same |
| GB0900961D0 (en) | 2009-01-20 | 2009-03-04 | Univ Bath | Antimicrobial coating |
| JP5593705B2 (en) | 2010-01-19 | 2014-09-24 | セントラル硝子株式会社 | Method for producing trialkylphosphine |
-
2012
- 2012-12-06 IN IN4596DEN2014 patent/IN2014DN04596A/en unknown
- 2012-12-06 WO PCT/IB2012/057029 patent/WO2013084185A1/en active Application Filing
- 2012-12-06 AU AU2012348569A patent/AU2012348569B2/en not_active Ceased
- 2012-12-06 EP EP12813988.8A patent/EP2788007B1/en active Active
- 2012-12-06 US US14/363,542 patent/US9676801B2/en not_active Expired - Fee Related
- 2012-12-06 CA CA2858325A patent/CA2858325C/en not_active Expired - Fee Related
-
2014
- 2014-06-04 ZA ZA2014/04068A patent/ZA201404068B/en unknown
-
2017
- 2017-05-09 US US15/590,767 patent/US10583109B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2858325C (en) | 2018-03-13 |
| US20150037256A1 (en) | 2015-02-05 |
| WO2013084185A1 (en) | 2013-06-13 |
| AU2012348569B2 (en) | 2016-09-01 |
| US20170239208A1 (en) | 2017-08-24 |
| EP2788007A1 (en) | 2014-10-15 |
| AU2012348569A1 (en) | 2014-07-03 |
| US9676801B2 (en) | 2017-06-13 |
| EP2788007B1 (en) | 2020-09-02 |
| CA2858325A1 (en) | 2013-06-13 |
| ZA201404068B (en) | 2015-04-29 |
| US10583109B2 (en) | 2020-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014501560A1 (en) | Carbamate compounds and of making and using same | |
| MY162903A (en) | Methods of treatment of pancreatic cancer | |
| PH12012502399A1 (en) | Combination therapy methods for treating proliferative diseases | |
| GB201118656D0 (en) | New compounds | |
| NZ729643A (en) | Combination therapy for treating cancer | |
| PH12015501964B1 (en) | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
| GB201209609D0 (en) | New compounds | |
| MY165624A (en) | N-acylsulfonamide apoptosis promoters | |
| MY188382A (en) | Spirocyclic inhibitors of cathepsin c | |
| PH12012500497A1 (en) | Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs | |
| IL206563A (en) | Therapeutic composition or medicament comprising a suspension of red corpuscles encapsulating asparginase for use in the treatment of pancreatic cancer | |
| PH12013501127A1 (en) | Use of sigma ligands in bone cancer pain | |
| IN2014MN00139A (en) | ||
| UA113849C2 (en) | THE APPLICATION OF SIGMA LIGANDS IN TYPE 2 PATIENTS WITH PAIN | |
| MX2015011359A (en) | Macrocyclic lrrk2 kinase inhibitors. | |
| MX2022011372A (en) | Zinc-î³-pga compositions and methods for treating cancer. | |
| GB0718878D0 (en) | Photodynamic Theraphy and diagnosis | |
| MA34815B1 (en) | COMPOSITIONS COMPRISING A PI3K INHIBITOR AND A MEK INHIBITOR AND THEIR USE FOR THE TREATMENT OF CANCER | |
| IN2014DN04596A (en) | ||
| WO2008070557A3 (en) | Organometallic complexes as therapeutic agents | |
| TW201129361A (en) | Methods for treating pain | |
| PH12013501968A1 (en) | Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias | |
| MX2022008632A (en) | Ccr5 binding agent for treatment of ccr5 positive metastatic cancer. | |
| WO2011070358A3 (en) | Systemic administration of an agent that permeabilises tumour vasculature | |
| WO2011131925A3 (en) | Osmium (ii) arene azo anti-cancer complexes |